Encompass Health EVP Darby sells 8,906 shares

Encompass Health Corp executive John Patrick Darby, EVP, General Counsel & Secretary, reported selling 8,906 shares of Encompass Health common stock on 2026-08-10 in an open-market or private transaction.

Rhea-AI Filing Summary

Encompass Health Corp executive John Patrick Darby, EVP, General Counsel & Secretary, reported selling 8,906 shares of Encompass Health common stock on 2026-08-10 in an open-market or private transaction. The weighted average sale price was $125.95 per share, across multiple trades between $125.94 and $126.04, leaving him with 75,041 shares held directly after the sale.

Insider Trade Summary

Net Seller: 8,906 shares

Net Sell 1 txn

Insider Darby John Patrick

Role EVP, Gen Counsel & Secretary

Sold 8,906 shs ($1.12M)

Type	Security	Shares	Price	Value
Sale	Encompass Health Common Stock F1	8,906	$125.95	$1.12M

Holdings After Transaction: Encompass Health Common Stock — 75,041 shares (Direct)

Footnotes (1)

1. F1. This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.94 to $126.04, inclusive. The reporting pers on undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Key Figures

Shares sold: 8,906 shares Weighted average sale price: $125.95 per share Sale price range: $125.94–$126.04 per share +1 more

4 metrics

Shares sold 8,906 shares Encompass Health common stock sold on 2026-08-10

Weighted average sale price $125.95 per share Average price for 8,906 shares sold

Sale price range $125.94–$126.04 per share Range of prices for multiple transactions included in the sale

Shares owned after sale 75,041 shares Direct holdings of John Patrick Darby following the transaction

Key Terms

weighted average price, open market or private transaction, security holders

3 terms

weighted average price financial

"This per share price is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction market

"Transaction code S described as Sale in open market or private transaction"

security holders financial

"provide to Encompass Health Corporation, any of its security holders, or the staff"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Encompass Health (EHC) report for John Patrick Darby?

Encompass Health reported that John Patrick Darby sold 8,906 shares of Encompass Health common stock on 2026-08-10 in an open-market or private transaction at a weighted average price of $125.95 per share.

At what price did John Patrick Darby sell Encompass Health (EHC) shares?

John Patrick Darby sold shares at a weighted average price of $125.95 per share. The filing states the shares were sold in multiple transactions at prices ranging from $125.94 to $126.04 per share, inclusive.

How many Encompass Health (EHC) shares did John Patrick Darby sell?

John Patrick Darby sold 8,906 shares of Encompass Health common stock. According to the filing, these sales were executed on 2026-08-10 as a single reported transaction comprised of multiple trades within a narrow price range.

How many Encompass Health (EHC) shares does John Patrick Darby own after the reported sale?

Following the sale, John Patrick Darby directly owns 75,041 shares of Encompass Health common stock. This post-transaction holding is disclosed in the Form 4 as the total number of shares he held directly after the reported transaction.

Was the Encompass Health (EHC) insider sale executed in multiple trades?

Yes. The filing notes the per-share price is a weighted average and that the 8,906 shares were sold in multiple transactions at prices between $125.94 and $126.04 per share, with detailed breakdowns available on request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/11/2026 - 02:47 PM Accepted by SEC EDGAR 08/11/2026 - 02:47 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Darby John Patrick

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Gen Counsel & Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	08/10/2026		S		8,906	D	$125.95(1)	75,041	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.94 to $126.04, inclusive. The reporting pers on undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Remarks:

	John Patrick Darby, EVP General Counsel & Secretary	08/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)